Reviewing the compounding risks for tuberculosis drug-induced liver injury in a patient with transfusion dependent thalassaemia

Citation

Rofii, Nursafinas and Daut, Ummi Nadira and Lau, Su Yin (2023) Reviewing the compounding risks for tuberculosis drug-induced liver injury in a patient with transfusion dependent thalassaemia. Malaysian Journal of Medicine and Health Sciences, 19 (4). 365- 367. ISSN 1675-8544; ESSN: 2636-9346

Abstract

A patient presents with jaundice three weeks into commencement of anti-tuberculosis therapy (ATT). Tuberculosis drug-induced liver injury (TB-DILI) is a main concern in patients commencing ATT. Studies have reported various risk factors associated with TB-DILI, urging vigilance in monitoring liver enzymes in these patients. We aim to review the causes of jaundice in a patient with transfusion dependent thalassaemia commenced on ATT and highlight the risk factors associated with TB-DILI.

Download File

Text
Reviewing the compounding risks for tuberculosis drug-induced liver injury.pdf
Download (76kB)

Official URL or Download Paper: https://medic.upm.edu.my/jurnal_kami/volume_19_202...

Additional Metadata

Item Type:	Article
Divisions:	Faculty of Medicine and Health Science Hospital Pengajar UPM
DOI Number:	https://doi.org/10.47836/mjmhs.19.4.51
Publisher:	Universiti Putra Malaysia
Keywords:	Antitubercular agents; Case report; Drug-induced liver injury; Tuberculosis; Thalassaemia major
Depositing User:	Ms. Nur Faseha Mohd Kadim
Date Deposited:	05 Aug 2024 04:25
Last Modified:	05 Aug 2024 04:25
Altmetrics:	http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.47836/mjmhs.19.4.51
URI:	http://psasir.upm.edu.my/id/eprint/109343
Statistic Details:	View Download Statistic

Actions (login required)

View Item